Self-assembling peptides for caries prevention and treatment of initial carious lesions, a review

DOI: 10.3238/dzz-int.2020.0021-0025

PDF

,

Keywords: P11-4 biomimetic remineralization caries prevention enamel minimal invasive treatment pediatric dentistry self-assembling peptide

Abstract: The shift from reparative to regenerative dentistry reflects the current trend in medicine and also mirrors the new understanding of caries as a chronic disease. Selfassembling peptide P11-4 showed promising results in the regenerative biomimetic remineralization of initial carious lesions. This approach may present safe and acceptable preventive and minimal invasive treatment for initial caries in children and adolescents. Further studies it is suggested to investigate this novel approach in treatment of molar incisor hypomineralization and cavitated carious lesions.

Preventive & Pediatric Dentistry University of Greifswald, Fleischmannstr. 42, 17487 Greifswald: OA Priv.-Doz Dr. Mohammad Alkilzy, Prof. Dr. Christian Splieth

Citation: Alkilzy M, Splieth CH: Self-assembling peptides for caries prevention and treatment of initial carious lesions, a review. Dtsch Zahnärztl Z Int 2020; 2: 021–025

Peer-reviewed article: submitted: 04.09.2019, revised version accepted: 30.10.2019

DOI.org/10.3238/dzz-int.2020.0021–0025

Introduction

Dental caries is a chronic, infectious, progressive disease, starting with ini­tial loss of tooth minerals and leading to total tooth destruction over time. Caries occurs when an imbalance between re- and de-mineral­ization takes place at the site of loss of minerals in hard dental tissue [23]. Therefore, the classic “treatment” of cavities by drilling and filling constitutes repair of the damage, but does not treat the disease itself. “Real” ca­ries treatment would consist of shifting the equilibrium to re-mineral­ization, for instance by improving the daily oral hygiene regime, healthy diet and fluoride application. The new understanding of caries kinetics and monitoring the de-/re-mineralization equilibrium can indicate measures for correcting the mineralization balance [10]. In the early stages of caries, prior to the cavitation of the enamel surface, many non- and minimally invasive treatments have been suggested to avoid further tooth destruction and subsequently restorations. The primary aim of non-invasive treatments is to inactivate or arrest the caries. This can be achieved by diet control and plaque removal which allows the carious lesions to remineralize naturally through saliva [9]. The presence of fluorides clearly enhances remineralization and prevents further demineralization [19, 22]. Unfortunately, most preventive approaches rely on changes in the patient’s behaviour, but this is not always an easy job especially in children and adolescences. A possible alternative is sealing caries risk surfaces mechan­ically [2], but sealants are prone to microleakage and subsequent caries in the long run [13] (Fig. 1).

An alternative approach to the current strategies for managing initial non-cavitated carious lesions is the recently introduced self-assembling peptide P11-4 [1] for regenerating demineralized tooth tissue. This peptide forms a 3D-matrix within demineralized carious lesions, which enables novo hydroxyapatite crystal for­mation facilitating the regeneration of the lost enamel structure [10, 15] (Fig. 2). The peptide has shown encouraging results as a scaffold for enamel regeneration [26]. This paper presents the current scientific evidence and clinical implementations for the self-assembling peptide P11-4 in a modern caries management.

Biomimetics with self- assembling peptides

The self-assembling peptide P11-4 is clinically available as Curodont Repair and it has the chemical structure: Ace-Gln-Gln-Arg-Phe-Glu-Trp-Glu-Phe-Glu-Gln-Gln-NH2. It is synthetic and manufactured under cGMP and contains no human- or animal-derived components. Biocompatibility studies (according to ISO 10993 or equivalent) have shown that P11-4 did not raise any cytotoxic effects or any immunological response [7, 12, 18]. P11-4 has been proven safe in animals and patients in vivo. No adverse device effects have been reported so far [3].

Conditions and indications for minimal invasive caries treatment with SAP

Limitations and contra-indications for minimal invasive caries treatment with SAP

Active initial lesions without cavitation (Fig. 4)

Carious lesion with cavitation

Lack in the patient’s compliance with toothbrushing and dental hygiene

Good patient’s compliance to dental hygiene

Moderate caries risk and activity

Patients with low caries risk

Age groups with elevated caries activity such as adolescences and young adults

Elderly patients with slow caries progression or already arrested lesions

Progression of the lesion in spite of preventive approaches

Patients with allergy to one or more elements of the product

Table 1 Indications and limitations for minimal invasive caries treatment with SAP

P11-4 undergoes under specific physicochemical conditions and above a critical concentration a hierarchical self-assembly to form tapes and ribbons within seconds, and fibrils and fibers within the following 24 h [1, 6, 8] (Fig. 3). These resulting self-assembling peptide fibres forming the 3D Self-Assembling Peptide Matrix (SAPM) can grow to a significant length. If the conditions for self-assembly are given, the assembly process cannot be stopped at the intermediates unless no more monomeric peptides are available. Confocal microscopy and mass spectroscopy showed that monomeric P11-4 diffuses through the pores of demineralized enamel, where fibre formation is triggered and the 3D matrix is formed [16]. Furthermore, C-labeled P11-4 indicated that about 35 % of P11-4 remained within artificial carious lesions [16] being available for de novo hydroxyapatite crystal for­mation. Two studies [10, 15] used the microtomography (microCT) analysis of remineralized specimens and found a remineralization of up to 90 % of the original enamel density.

A series of in-vitro studies insured the high affinity of the P11-4 matrix for Ca2 ions and its action as a nucleator for de novo hydroxyapatite formation [6, 16, 17, 25]. Furthermore, the P11-4 fibers bind to the already existing Ca2 ions of the hydroxyapatite lattice of the tooth enamel [6], enabling stable bridge binding of the new regenerated enamel to the tooth hard tissue. A study of Kind et al. [16] investigated the diffusion of P11-4 into a carious lesion by time resolved confocal microscopy pictures. The results showed that the P11-4 diffuses beyond the volume of the carious lesion into the enamel layer below as was defined as the carious lesion on a microradiograph. After the formation of fibres is complete the formed fibers seem to occupy the observed lesion.

Clinical implementation of self-assembling peptide

Feasibility of clinical application, safety and clinical effect of P11-4 were first examined in an un-controlled safety trial treating arrested carious lesions on buccal surfaces in 15 adults [6]. As no adverse events were recorded by the use of the product and the blinded evaluation of the lesions showed a significant improvement of lesions judged by colour, size and perceived progression, further clinical studies were feasible. Table 1 lists some clinical indications and limitations for minimal invasive caries treatment with self-assembling peptides (SAP).

Self-assembling peptide for non- and minimal invasive treatment of occlusal initial caries

Occlusal surfaces of erupting permanent molars are highly prone to ca­ries. Because of the infra-occlusal position of these teeth during the eruption, an effective toothbrushing is difficult. Even sealing of these teeth presents almost difficulties because of the gingiva covering the occlusal surfaces in partially erupted teeth (Fig. 4). Therefore, a random­ized controlled single-blind study was conducted by Alkilzy et al. [3, 4] on children with visible active early caries on erupting permanent molars to investigate the safety and clinical efficacy of P11-4 for treatment of initial caries. Subjects were randomized to either the test group (P11-4 fluoride varnish) or control group (fluoride varnish alone). Caries was assessed at baseline and at 3– and 6-month post treatment per laser fluorescence, a visual analog scale, the International Caries Detection and Assessment System (ICDAS), and the Nyvad caries activity criteria [21]. Safety and clinical feasibility of the treatment approaches were also assessed. The P11-4 (Curodont Repair) was applied according to the instruction of the manufacturer (Fig. 5). Compared with the control group, the test group showed clinically and statistically significant improvement in all outcomes at 3– and 6-month follow-ups. The laser fluorescence readings (odds ratio = 3.5, P = 0.015) and visual analog scale scores (odds ratio = 7.9, P < 0.0001) were significantly lower for the test group, and they showed regression in ICDAS scores (odds ratio = 5.1, P = 0.018) and conversion from active to inactive lesions according to Nyvad criteria (odds ratio = 12.2, P < 0.0001, Fig. 6). Results suggest that Curodont Repair may present a simple, safe and effective non-invasive treatment for early occlusal carious lesions on erupting teeth in conjunction with topical fluoride. Figure 3 shows a treatment of an initial carious lesion in the occlusal surface of first permanent molar during eruption using Curodont Repair.

Self-assembling peptide for caries prevention in patients with orthodontic brackets

Jablonski-Momeni et al. [14] investigated in a randomised, cross-over in situ trial the ability of 1,000 ppm self-assembling peptide P11-4 (Curodont Protect) to remineralize artificial ini­tial caries lesions compared to the use of 22,600 ppm fluoride varnish. Laser fluorescence values (LF) and Micro-CT analysis was used to assess mineral changes within the specimens. The test group with P11-4 showed significantly more remineralization than the negative (p = 0.01) and positive control with fluoride (p = 0.003). The authors concluded that P11-4 showed prevention of caries and remineralization of enamel around orthodontic brackets.

The manufacturer of Curodont Protect claims that once the product is applied on the surface of the tooth the fibres can bind to the tooth via the Ca2 -binding sites to the aprismatic HA crystal on the surface of the tooth. As the surface of the tooth – which undergoes constant re-, demineralisation – is not prismatic in structure the long axis of the HA crystal is available for binding, and the natural zeta-potential of the enam­el surface seems to facilitate the binding. As a result, the 3D matrix will bind onto the tooth surface with multiple binding sites.

Self-assembling peptide for treatment of buccal caries and white spots

Bröseler et al. [5] compared in a prospective, randomized, split-mouth, clinical trial the efficacy of the self-assembling peptide P11-4 to fluoride varnish in the treatment of early buccal carious lesions. Subjects with at least 2 clinically affected teeth were treated at day one D0 and day 90 D90 with P11-4 (test) or fluoride varnish (control). At day 180, fluoride varnish was applied on all study lesions. Standardized photographs were taken at D0, D30, D90, D180 and D360 and the decrease in size between test and control groups was blindly morphometrically assessed. The results showed a significant difference between test and control groups, indicating a decrease in test lesions and stabilization of control lesions size (p = 0.001). The authors concluded that the size of early carious lesions treated with P11-4 was significantly reduced and this size reduction was superior to that of fluoride varnish treatment.

Self-assembling peptide for treatment of proximal caries

A study by Schlee et al. [24] investigated the clinical performance of self-assembling peptide P11-4 on non-cavitated initial proximal carious lesions 12 months after treatment. Twenty-six patients with 35 carious lesions were included in a practice-based case series. The x-rays of the proximal lesions at baseline and at day 360 were evaluated pairwise in a randomized and blinded manner with respect to the time point. The one-year results showed a predominant shift toward regression of the initial lesions, with 20 of 28 lesions showing total or partial regression, 4 unchanged, and 4 progressing. The authors suggested that the initial proximal carious lesions can regress after treatment with P11-4, but additional factors might influence the overall treatment outcome.

Summary and suggestions

The shift from reparative to regenerative dentistry reflects the current trend in medicine and also mirrors the new understanding of caries as a chronic disease. Self-assembling peptide P11-4 showed promising results in the regenerative biomimetic remineralization of initial carious lesions. This approach may present safe and acceptable preventive and minimal invasive treatment for ini­tial caries in children and adolescents. However, studies with longer observation periods are needed to confirm the consistent effect of P11-4. Further studies are suggested to investigate this approach in treatment of molar incisor hypomineral­ization and cavitated carious lesions.

Conflict of interest:

The authors state that they have no conflict of interest as defined by the guidelines of the International Committee of Medical Journal Editors.

References

  1. Aggeli A, Fytas G, Vlassopoulos D, McLeish TC, Mawer PJ, Boden N: Structure and dynamics of self-assembling beta-sheet peptide tapes by dynamic light scattering. Biomacromolecules 2001; 2: 378–388
  2. Ahovuo-Saloranta A, Forss H, Walsh et al.: Sealants for preventing dental decay in the permanent teeth. Cochrane Database Syst Rev 2013; March 28;(3):CD001830. doi: 10.1002/ 14651858.CD001830.pub4.
  3. Alkilzy M, Tarabaih A, Santamaria RM, Splieth CH: Self-assembling peptide P11-4 and fluoride for regenerating enamel. J Dent Res 2018; 97: 148–154
  4. Alkilzy M, Santamaria R. M, Schmoeckel J, Splieth CH: Treatment of carious lesions using self-assembling peptides. Adv Dent Res 2018; 29: 42–47
  5. Bröseler F, Tietmann C, Bommer C, Drechsel T, Heinzel-Gutenbrunner M, Jepsen S: Randomised clinical trial investigating self-assembling peptide P11-4 in the treatment of early caries. Clin Oral Investig 2019 Apr 29. doi: 10.1007/ s00784–019–02901–4
  6. Brunton PA, Davies RP, Burke JL et al.: Treatment of early caries lesions using biomimetic self-assembling peptides – a clinical safety trial. Br Dent J 2013; 215: E6
  7. Burke, JL: In situ engineering of skeletal tissues using self-assembled biomimetic scaffolds, in Leeds Dental Institute. The University of Leeds, Leeds 2011, p. 1–277
  8. Davies RP, Aggeli A, Beevers AJ et al.: Self-assembling β-sheet tape forming peptides. Supramolecular Chemistry 2006; 18: 435–443
  9. de Almeida Pdel V, Grégio AM, Machado MA, de Lima AA, Azevedo LR: Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 2008; 9: 72–80
  10. Deyhle H, Dziadowiec I, Kind L, Thalmann P, Schulz G, Müller B: Mineralization of early stage carious lesions in vitro – a quantitative approach. Dent J 2015; 3: 111–122
  11. Editorial. Nature medicine 2014; 20: 795
  12. Felton S: Self assembling b-sheet peptide networks as smart scaffolds for tissue engineering, in chemistry. University of Leeds, Leeds 2005, p. 184
  13. Heyduck C, Meller C, Schwahn C, Splieth CH: Effectiveness of sealants in adolescents with high and low caries experience. Caries Res 2006; 40: 375–381
  14. Jablonski-Momeni A, Korbmacher-Steiner H, Heinzel-Gutenbrunner M, Jablonski B, Jaquet W, Bottenberg P: Random­ised in situ clinical trial investigating self-assembling peptide matrix P11-4 in the prevention of artificial caries lesions. Sci Rep 2019; 9: 269. doi: 10. 1038/s41598–018–36536–4
  15. Kang J, Davies RP, Brookes SJ, Kirkham J: Multi-level modelling to further understanding of micro-CT data. In proceedings, enamel 9 conference in Harrogate, University of Leeds, Leeds 2016, Abstract 68
  16. Kind L, Stevanovic S, Wuttig S et al.: Biomimetic remineralization of carious lesions by self-assembling peptide. J Dent Res 2017; 96: 790–797
  17. Kirkham J, Firth A, Vernals D et al.: Self-assembling peptide scaffolds promote enamel remineralization. J Dent Res 2007; 86: 426–30
  18. Kyle S, Aggeli A, Ingham E, McPherson MJ: Recombinant self-assembling peptides as biomaterials for tissue engi­neering. Biomaterials 2010; 31: 9395–9405
  19. Marinho, VC, Worthington HV, Walsh T, Clarkson JE: Fluoride varnishes for preventing dental caries in children and adolescents. Cochrane Database Syst Rev 2013 Juli 11;(7):CD002279. doi: 10.1002/14651858.CD002279.pub2
  20. Marthaler TM: Changes in dental caries. Caries Res 2004; 38: 173–181
  21. Nyvad B, Machiulskiene V, Bælum V: The Nyvad criteria for assessment of ca­ries lesion activity. In: Stookey GK (editor): Clinical models workshop: remin-demin, precavitation, caries: proceedings of the 7th Indiana Conference, Indianapolis, Indiana, USA. Indiana University School of Dentistry 2005, p. 99–116
  22. Petersson LG, Twetman S, Pakhomov GN: The efficiency of semiannual silane fluoride varnish applications: a two-year clinical study in preschool children. J Public Health Dent 1998; 58: 57–60
  23. Pitts NB, Zero DT, Marsh PD et al.: Dental caries. Nat Rev Dis Primers 2017; May 25; (3):17030. doi: 10.1038/ nrdp.2017.30
  24. Schlee M, Schad T, Koch JH, Cattin PC, Rathe F: Clinical performance of self-assembling peptide P11-4 in the treatment of initial proximal carious lesions: A practice-based case series. J Investig Clin Dent 2018; 9: e12286
  25. Sousa J, Carvalho RG, Barbosa-Martins LF, Tersariol IL, Nascimento FD, Puppin-Rontani RM: Peptide P11-4 acts as a nucleator of hydroxyapatite crystals formation. J Dent Res 2017; 96(Spec. Iss. A): 3297
  26. Thomson BM, Hardaker L, Davies RPW et al.: P11–15 (NNRFEWEFENN): a second generation biocompatible, self- assembling peptide with potential to promote enamel remineralization. Caries Res 2014; 48: 384–450 (Abs. Nr. 47)

PD Dr. Mohammad Alkilzy

Dep. of Preventive & Pediatric Dentistry, University of Greifswald, Fleischmannstr. 42, 17487 Greifswald, Germany alkilzym@uni-greifswald.de

(Photo: private)

Prof. Dr. Christian Splieth

Dep. of Preventive & Pediatric Dentistry, University of Greifswald, Fleischmannstr. 42, 17487 Greifswald, Germany

splieth@uni-greifswald.de

(Photo: private)


related files

PDF

(State: 15.01.2020)

Latest Issue 1/2020

In Focus

  • Changing the bite position in a patient with tooth hard substance loss
  • Self-assembling peptides for caries prevention and treatment